The association between dietary protein intake and metabolic syndrome: a GRADE-assessed systematic review and meta-analysis of observational studies
Related Experiment Video
Updated: Jan 7, 2026

An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
Published on: April 20, 2018
Dorsa Ghazvineh1, Ali Hosseinpour2, Vahid Basirat3
1Department of Exercise Physiology, K.C.*, Islamic Azad University of Karaj, Karaj, Iran.
Objectives:
The primary aim of this meta-analysis is to assess the association of dietary protein with the risk of metabolic syndrome (MetS) in observational studies. In addition, the secondary aim is to evaluate the effectiveness of protein intake on MetS components.
Methods:
An Initial search was conducted from PubMed, Web of Science (WOS), and Scopus until May 2024. Cohort, cross-sectional, and case-control studies were included, and their quality and certainty were evaluated by the Newcastle - Ottawa Quality Assessment Scale (NOS) and the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) tools, respectively.
Result:
Based on our meta-analysis, we found that plant protein (PP), and animal protein (AP) had an inverse association with MetS (OR: 0.77, 95% CI: 0.69, 0.87, P < 0.001; I2 = 93.0%; Pheterogeneity < 0.001), (OR: 0.92, 95% CI: 0.86, 0.98, P = 0.012; I2 = 83.5%; Pheterogeneity < 0.001), respectively. Besides, there was no association between total protein (TP) and MetS (OR: 0.90, 95% CI: 0.82, 1.00, P < 0.051; I2 = 91.3%; Pheterogeneity < 0.001) as the primary outcomes. Furthermore, TP, AP, and PP had a negative association with MetS components, except TP-WC (OR: 0.78; 95% CI: 0.55, 1.12; P = 0.178; I2 = 80.0%; Pheterogeneity < 0.001), TP-FBS (OR: 0.93; 95% CI: 0.82, 1.05; P = 0.231; I2 = 91.0%; Pheterogeneity < 0.001), TP-BP (OR: 0.86; 95% CI: 0.76, 0.96; P = 0.008; I2 = 87.9%; Pheterogeneity < 0.001), AP-FBS (OR: 1.04, 95% CI: 1.00, 1.07, P = 0.061; I2 = 29.6%; Pheterogeneity >0.001), PP-FBS (OR: 0.94, 95% CI: 0.86, 1.03, P = 0.207; I2 = 72.2%; Pheterogeneity =0.001).
Conclusion:
Current evidence suggests that PP and AP intake may be associated with reduced risk of MetS as the primary outcome. However, in specific contexts, such as some of the secondary outcomes, results showed no reaction, e.g., TP-WC, TP-FBS, TP-BP, AP-FBS, PP-FBS. Besides, due to the high heterogeneity, methodological quality, and significant bias in PP-MetS and PP-TG, recommendations must be made cautiously. Finally, no definitive conclusions can be drawn regarding a causal or uniform protective relationship.
Trial Registration:
Prospero ID 1020957.
More Related Videos
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
09:44Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Related Concept Videos
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Proteins: Dietary Sources and Requirements
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Coronary Artery Disease I: Introduction